Qualitas Medical Group once again stands out among other healthcare leaders with two wins at the Healthcare Asia Awards 2021.
The two accolades are Primary Care Provider of the Year and Covid Management Initiative of the Year.
By striving to deliver highly accessible medical services while sustaining quality healthcare, Qualitas remains steadfast in providing quality primary healthcare to communities across the Asia Pacific. This commitment was further reinforced during the Covid-19 outbreak that reached pandemic proportions in March 2020.
Acutely aware of their responsibility to carry their frontline role through their wide network of GP clinics across Malaysia, where communities have come to rely on its doctors and healthcare staff to provide reliable diagnosis and treatment, Qualitas took the initiative not just play its part, but to lead the country in their Covid-19 testing.
When there is a communicable disease outbreak, the definitive response is for testing to begin early. This leads to quick identification of cases, rapid treatment of patients and immediate isolation to prevent its spread. Testing also plays a major part in the bigger picture of public health – in mitigation efforts, helping investigators characterise the prevalence, spread and contagiousness of the disease. Ultimately, testing reduces the enormous burden on public and private clinical facilities in treating positive cases.
Due to its decades-long role as a healthcare company
Qualitas Medical Group was able to immediately strengthen its existing facilities within its network, upscaling quickly to cope with the pandemic, including being able to access adequate testing kits, laboratory time and by deploying doctors, nurses and auxiliary medical teams across the nation.
One such effort by Qualitas was the Ministry of Health sanctioned home sampling that began as early as March 2020, even as the rest of the world was still trying to figure out the best way to deal with the pandemic. With the success of home sampling came the need to test on a larger scale. As the demand for testing rose, Qualitas embarked on programmes to empower more healthcare staff. One such programme was the ‘Earn As You Learn’ programme
where Qualitas trained fresh medical school graduates to assist in the COVID-19 testing team as part of their on-the-ground training.
Milestones were achieved for Qualitas when COVID-19 screening was carried out for various industries such as construction
Manufacturing, information technology and FMCG.
The massive on-site testing once again demonstrated the agility and efficiency of Qualitas,
key elements in tackling a public health crisis.
Quality Medical Group has always been at the forefront of quality global healthcare
A commitment will continue to make through accessible healthcare for everyone via 250
medical centres across South East Asia and the Asia Pacific.
Most individuals above the age of 6 months can receive the influenza vaccine as long as they do not have an existing allergic reaction to any of the components of the influenza vaccine, especially allergic reactions to egg protein.
It will take approximately 2 weeks after vaccination for your body to produce antibodies against the vaccine strains. Thus, it is important to get your vaccination before the flu season starts. The influenza strains undergo continuous changes and the influenza vaccines need to be “updated” every season. As a result, you need to receive annual influenza vaccinations.
Fluarix Tetra registered in Singapore covers 4 strains – 2 for influenza A and 2 for influenza B.
We are pleased to inform you that it is now available at our clinic.
From 1 November 2020 Under the Enhanced Subsidies for the Vaccination Subsidy Scheme, Pioneer and Merdeka Generation patients will only need to Co-pay $9/$18 for the vaccine.
